{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:25:18Z","timestamp":1783164318296,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05461-6","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:48:24Z","timestamp":1766396904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lp(a) Testing in Latin America: Low Awareness and Clinicalpractice Among Medical Society Physicians Highlight a Missed Opportunity in Cardiovascular Prevention"],"prefix":"10.1186","volume":"26","author":[{"given":"Ivette","family":"Cruz-Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuscely","family":"Flores-Jurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Barajas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulino","family":"Castillo-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"El\u00edas-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Ramos-Guifarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Barrera-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizbeth","family":"Ruilova-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misael","family":"Aguilar-Panduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Mu\u00f1oz-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel N.","family":"Faradji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"M\u00e1rquez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Carlos Garnica-Cuellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Guti\u00e9rrez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"de Jes\u00fas Gardu\u00f1o-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alberto","family":"\u00c1vila-Funes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Guerra-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejo","family":"Diaz-Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Ruiz-Gastelum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cossio-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Velasco-Solorzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos O.","family":"Mend\u00edvil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Patricio","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Morales-Esponda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alberto Aguilar -Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Grupo L\u00edpidos SMNE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"Aguilar-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Caracas-Portilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PA","family":"Carrillo-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JJ","family":"Ceballos-Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Espinoza-Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gallegos-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Madriz-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pe\u00f1a-Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ram\u00edrez Cooremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Reza-Albarr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Romero-Zazueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sauque-Reyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Torres-Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Zubir\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"3","key":"5461_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jacc.2023.10.039","volume":"83","author":"E Bj\u00f6rnson","year":"2024","unstructured":"Bj\u00f6rnson E, Adiels M, Taskinen MR, Burgess S, Chapman MJ, Packard CJ, et al. Lipoprotein(a) is markedly more atherogenic than LDL: an Apolipoprotein B-Based genetic analysis. J Am Coll Cardiol. 2024;83(3):385\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"5461_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas S. A test in context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and emerging therapies. J Am Coll Cardiol. 2017;69(6):692\u2013711.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5461_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","volume":"7","author":"F Duarte Lau","year":"2022","unstructured":"Duarte Lau F, Giugliano RP. Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. JAMA Cardiol. 2022;7(7):760\u20139. Available from: https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2792280. Cited 2025 Apr 5.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"5461_CR4","doi-asserted-by":"publisher","first-page":"E48","DOI":"10.1161\/ATV.0000000000000147","volume":"42","author":"G Reyes-Soffer","year":"2022","unstructured":"Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al. Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific Statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(1):E48\u201360. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/ATV.0000000000000147. Cited 2025 Apr 5.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5461_CR5","doi-asserted-by":"crossref","unstructured":"Catapano AL, Daccord M, Damato E, Humphries SE, Neely RDG, Nordestgaard BG et al. How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)? Atherosclerosis. 2022;349:136\u201343. Available from: https:\/\/www.atherosclerosis-journal.com\/action\/showFullText?pii=S002191502200082X. Cited 2025 Apr 5.","DOI":"10.1016\/j.atherosclerosis.2022.02.013"},{"issue":"2","key":"5461_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ihj.2019.03.004","volume":"71","author":"EA Enas","year":"2019","unstructured":"Enas EA, Varkey B, Dharmarajan TS, Pare G, Bahl VK. Lipoprotein(a): an independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Indian Heart J. 2019;71(2):99. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6620428\/. Cited 2025 Apr 5.","journal-title":"Indian Heart J"},{"issue":"11","key":"5461_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/clc.23456","volume":"43","author":"AN Berman","year":"2020","unstructured":"Berman AN, Biery DW, Ginder C, Hulme OL, Marcusa D, Leiva O, et al. Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design and rationale of the Mass General Brigham Lp(a) Registry. Clin Cardiol. 2020;43(11):1209\u201315. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/clc.23456. Cited 2025 Apr 5.","journal-title":"Clin Cardiol"},{"issue":"23","key":"5461_CR8","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K, Bor\u00e9n J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31(23):2844. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3295201\/. Cited 2025 Apr 7.","journal-title":"Eur Heart J"},{"issue":"3","key":"5461_CR9","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","volume":"18","author":"ML Koschinsky","year":"2024","unstructured":"Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18(3):e308\u201319.","journal-title":"J Clin Lipidol"},{"issue":"91","key":"5461_CR10","first-page":"001","volume":"11","author":"CA Aguilar-Salinas","year":"2024","unstructured":"Aguilar-Salinas Aguilar-Salinas CA, Cruz-Bautista I, Pe\u00f1a-Aparicio B, Ceballos-Mac\u00edas JJ, Romero-Zazueta A, Sauque-Reyna L, et al. Documento de postura de la Sociedad Mexicana de Nutrici\u00f3n y Endocrinolog\u00eda: diagn\u00f3stico y tratamiento de las dislipidemias. Revista Mexicana de Endocrinolog\u00eda. Metabolismo y Nutrici\u00f3n. 2024;11(91):001\u201328.","journal-title":"Metabolismo y Nutrici\u00f3n"},{"key":"5461_CR11","first-page":"1","volume":"92","author":"AA Pav\u00eda-L\u00f3pez","year":"2022","unstructured":"Pav\u00eda-L\u00f3pez AA, Alcocer-Gamba MA, Ruiz-Gastelum ED, Mayorga-Butr\u00f3n JL, Mehta R, D\u00edaz-Arag\u00f3n FA, et al. Gu\u00eda de pr\u00e1ctica cl\u00ednica mexicana para el diagn\u00f3stico y tratamiento de las dislipidemias y enfermedad cardiovascular ateroscler\u00f3tica. Arch Cardiol Mex. 2022;92:1\u201362. Available from: http:\/\/www.scielo.org.mx\/scielo.php?script=sci_arttext%26;pid=S1405-99402022000500001%26;lng=es%26;nrm=iso%26;tlng=es. Cited 2025 Apr 23.","journal-title":"Arch Cardiol Mex"},{"issue":"1","key":"5461_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","volume":"290","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, Koskina KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290(1):140\u2013205. Available from https:\/\/pubmed.ncbi.nlm.nih.gov\/31504418\/. Cited 2025 Apr 23.","journal-title":"Atherosclerosis"},{"issue":"0","key":"5461_CR13","doi-asserted-by":"publisher","first-page":"119218","DOI":"10.1016\/j.atherosclerosis.2025.119218","volume":"0","author":"F Kronenberg","year":"2025","unstructured":"Kronenberg F, Bedlington N, Ademi Z, Geant\u0103 M, Silberzahn T, Rijken M, et al. The Brussels International Declaration on Lipoprotein(a) Testing and Management. Atherosclerosis. 2025;0(0):119218. Available from: https:\/\/www.atherosclerosis-journal.com\/action\/showFullText?pii=S0021915025001169. Cited 2025 Jun 5.","journal-title":"Atherosclerosis"},{"issue":"39","key":"5461_CR14","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","volume":"43","author":"F Kronenberg","year":"2022","unstructured":"Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925\u201346. Available from: https:\/\/doi.org\/10.1093\/eurheartj\/ehac361. Cited 2025 Apr 5.","journal-title":"Eur Heart J"},{"issue":"18","key":"5461_CR15","doi-asserted-by":"publisher","first-page":"31255","DOI":"10.1161\/JAHA.123.031255","volume":"12","author":"HS Bhatia","year":"2023","unstructured":"Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. J Am Heart Assoc. 2023;12(18):31255. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.123.031255. Cited 2025 Apr 6.","journal-title":"J Am Heart Assoc"},{"key":"5461_CR16","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.ajpc.2024.100886","volume":"20","author":"M Manzato","year":"2024","unstructured":"Manzato M, Meeusen JW, Donato LJ, Jaffe AS, Vasile VC. Lipoprotein (a) testing patterns among subjects with a measured lipid panel: The Mayo Clinic experience. Am J Prev Cardiol. 2024;20:100886. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11539117\/. Cited 2025 Apr 6.","journal-title":"Am J Prev Cardiol"},{"key":"5461_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.atherosclerosis.2023.02.007","volume":"370","author":"AL Catapano","year":"2023","unstructured":"Catapano AL, Tokg\u00f6zo\u011flu L, Banach M, Gazzotti M, Olmastroni E, Casula M, et al. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. Atherosclerosis. 2023;370:5\u201311. Available from: https:\/\/www.atherosclerosis-journal.com\/action\/showFullText?pii=S0021915023000850. Cited 2025 Apr 23.","journal-title":"Atherosclerosis"},{"issue":"10","key":"5461_CR18","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1093\/eurjpc\/zwae155","volume":"31","author":"CC Faaborg-Andersen","year":"2024","unstructured":"Faaborg-Andersen CC, Cho SMJ, Natarajan P, Honigberg MC. Trends and disparities in lipoprotein(a) testing in a large integrated US health system, 2000\u201323. Eur J Prev Cardiol. 2024;31(10):e79\u201382. Available from: https:\/\/doi.org\/10.1093\/eurjpc\/zwae155. Cited 2025 Apr 27.","journal-title":"Eur J Prev Cardiol"},{"issue":"14","key":"5461_CR19","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1093\/eurjpc\/zwac124","volume":"29","author":"B Zafrir","year":"2022","unstructured":"Zafrir B, Aker A, Saliba W. Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider. Eur J Prev Cardiol. 2022;29(14):e331\u20133. Available from: https:\/\/doi.org\/10.1093\/eurjpc\/zwac124. Cited 2025 Apr 23.","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"5461_CR20","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.1016\/j.jacl.2024.02.004","volume":"18","author":"S Ansari","year":"2024","unstructured":"Ansari S, Neely RDG, Payne J, Cegla J. Lipoprotein(a) testing in lipid clinics across the UK: Results of a national survey. J Clin Lipidol. 2024;18(3):e477\u201381. Available from: https:\/\/www.lipidjournal.com\/action\/showFullText?pii=S1933287424000230. Cited 2025 Apr 23.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"5461_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.5551\/jat.65214","volume":"32","author":"PT Yang","year":"2025","unstructured":"Yang PT, Tang L, Guo HR, He YM, Qin YX, Yan L, et al. Prevalence of Lipoprotein(a) Measurement and its Association with Arteriosclerosis in Asymptomatic Individuals in China. J Atheroscler Thromb. 2025;32(4):513\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39443133\/. Cited 2025 Apr 23.","journal-title":"J Atheroscler Thromb"},{"key":"5461_CR22","doi-asserted-by":"crossref","unstructured":"Murdock DJ, Moll K, Sanchez RJ, Gu J, Fazio S, Geba GP, et al. Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world. Am J Prev Cardiol. 2024;19. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39281349\/. Cited 2025 Apr 23.","DOI":"10.1016\/j.ajpc.2024.100721"},{"key":"5461_CR23","doi-asserted-by":"crossref","unstructured":"D\u2019Souza J, Soffer DE, Bajaj A. Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania health system. J Clin Lipidol. 2024;18(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39289122\/. Cited 2025 Apr 23.","DOI":"10.1016\/j.jacl.2024.07.012"},{"key":"5461_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2023.01.014","volume":"367","author":"PE St\u00fcrzebecher","year":"2023","unstructured":"St\u00fcrzebecher PE, Schorr JJ, Klebs SHG, Laufs U. Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses. Atherosclerosis. 2023;367:24\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36764050\/. Cited 2025 Apr 23.","journal-title":"Atherosclerosis"},{"key":"5461_CR25","doi-asserted-by":"publisher","first-page":"1527351","DOI":"10.3389\/fcvm.2025.1527351","volume":"12","author":"WJ Loh","year":"2025","unstructured":"Loh WJ, Pang J, Simon O, Chan DC, Watts GF. Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore. Front Cardiovasc Med. 2025;12:1527351.","journal-title":"Front Cardiovasc Med"},{"key":"5461_CR26","doi-asserted-by":"publisher","unstructured":"Wong ND, Fan Y, Fan W, Ward J, Schludi B, Hu X. Clinician Awareness, Testing, and treatment for Lipoprotein(A): results from A large US National survey. J Am Coll Cardiol. 2025;85(12):391. Available https:\/\/doi.org\/10.1016\/S0735-1097(25)00875-7. Cited 2025 Apr 23.","DOI":"10.1016\/S0735-1097(25)00875-7"},{"issue":"1","key":"5461_CR27","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.jacadv.2024.101441","volume":"4","author":"KF Faridi","year":"2025","unstructured":"Faridi KF, Wu Q, Kim C, Spatz ES, Desai NR, Krumholz HM, et al. Utilizing the electronic health record to evaluate Lipoprotein(a) testing within a large regional health system. JACC Adv. 2025;4(1):101441.","journal-title":"JACC Adv"},{"key":"5461_CR28","doi-asserted-by":"crossref","unstructured":"Cruz-Bautista I, Flores-Jurado Y, Roa-\u00c1lvarez G, Salas-Aldana M, El\u00edas-Lopez DB, Hern\u00e1ndez-Franco RF, et al. Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution. Lipids in Health Dis. 2025;24(1):1\u201312. Available from: https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02610-w. Cited 2025 Jun 5.","DOI":"10.1186\/s12944-025-02610-w"},{"key":"5461_CR29","doi-asserted-by":"publisher","unstructured":"Loh WJ, Watts GF, Lum E. A short educational video for improving awareness and confidence of healthcare professionals in managing lipoprotein(a): a pilot study based on LILAC-for-Lp(a). Eur J Cardiovasc Nurs. 2025. Available from: https:\/\/doi.org\/10.1093\/eurjcn\/zvaf052. Cited 2025 Jul 5.","DOI":"10.1093\/eurjcn\/zvaf052"},{"key":"5461_CR30","doi-asserted-by":"crossref","unstructured":"Eid WE, Sapp EH, Conroy C, Bessinger C, Moody CL, Yadav R, et al. Increasing provider awareness of Lp(a) testing for patients at risk for cardiovascular disease: A comparative study. Am J Prev Cardiol. 2024;21:100895. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11666892\/.\u00a0Cited 2025 Jun 5.","DOI":"10.1016\/j.ajpc.2024.100895"},{"key":"5461_CR31","unstructured":"Favereaux S, Durlach V, Vercoustre B. Patient experience of heart disease with Elevated Lipoprotein(a): Views from a patient, his physician, and a patient association. Cardiol Ther. 2025;1\u201312. Available from: https:\/\/link.springer.com\/article\/10.1007\/s40119-025-00416-6. Cited 2025 Jun 5."},{"key":"5461_CR32","doi-asserted-by":"crossref","unstructured":"Eidensohn Y, Bhatla A, Ding J, Blumenthal RS, Martin SS, Marvel FA. Testing practices and clinical management of lipoprotein(a) levels: a 5-year retrospective analysis from the Johns Hopkins Hospital. Am J Prev Cardiol. 2024;19. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39070024\/. Cited 2025 Jun 5.","DOI":"10.1016\/j.ajpc.2024.100686"},{"key":"5461_CR33","unstructured":"Shah NP, Mulder H, Lydon E, Chiswell K, Hu X, Lampron Z. et al. Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health Systems. J Am Heart Assoc. 2024;13(21). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39494552\/. Cited 2025 Jun 5."},{"key":"5461_CR34","doi-asserted-by":"crossref","unstructured":"Kelsey MD, Mulder H, Chiswell K, Lampron ZM, Nilles E, Kulinski JP, et al. Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes. Am J Prev Cardiol. 2023;14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37025553\/. Cited 2025 Jun 5.","DOI":"10.1016\/j.ajpc.2023.100478"},{"issue":"2","key":"5461_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.eprac.2024.09.016","volume":"31","author":"SB Patel","year":"2025","unstructured":"Patel SB, Wyne KL, Afreen S, Belalcazar LM, Bird MD, Coles S, et al. American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia. Endocr Pract. 2025;31(2):236\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39919851\/. Cited 2025 Jun 5.","journal-title":"Endocr Pract"},{"key":"5461_CR36","doi-asserted-by":"publisher","unstructured":"Rivera FB, Cha SW, Linnaeus Louisse C, Carado GP, Magalong JV, Tang VA, et al. Impact of proprotein convertase subtilisin\/Kexin Type 9 inhibitors on Lipoprotein(a): a meta-analysis and meta-regression of randomized controlled trials. JACC Adv 2025 4(2):101549 https:\/\/doi.org\/10.1016\/j.jacadv.2024.101549}","DOI":"10.1016\/j.jacadv.2024.101549"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05461-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:54:19Z","timestamp":1769064859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-025-05461-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5461"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05461-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research and Ethics Committees of the National Institute of Medical Sciences and Nutrition Salvador Zubir\u00e1n declared this study exempt, as it used anonymous, minimal-risk data collected from health professionals without personal identifiers. Although this study did not involve patients or biological samples, it was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Participation was voluntary, and electronic informed consent was obtained on the survey landing page. Approval reference number: 4910. The study protocol was initially approved in December 2023 and reapproved in December 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors provided their final consent for publication of the manuscript. No personal or identifiable information is included in this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}